September 2013 Issue
Intent on making the virtual manufacturing model work, pharma's collaborating in new ways to drive risk out and quality into extended supply chains
Open collaboration, commitment and mutually agreed upon goals will accelerate the value of CRO alliances
Cartridge style activated carbon filters offer advantages over loose carbon in pharmaceutical ingredient production.
China's crackdown may ultimately prompt better, more ethical behavior by capitalist and communist alike
Conflicting goals between the FDA and Congress are creating an interesting “tug of war” across the Generics space
Why Pharma shouldn’t stop drinking
PAT-based analysis methodologies help see, quality and quantify subtle changes in dosage forms